News and Updates
FDA approves a new generic valsartan
The US Food and Drug Administration (FDA) has approved a new generic of angiotensin II receptor blocker (ARB), Diovan (valsartan). The FDA prioritized the review of this drug application to help relieve the recent shortage of this critical medicine as a result of multiple recalls of generic valsartan products from several manufacturers due to the finding that certain lots of valsartan and other ARB medicines contain nitrosamine impurities.
To continue reading this article
Continue reading your article with a eMediNexus account.